Vanguard Group Inc. Sells 461,225 Shares of Masimo Corporation $MASI

Key Points

• Vanguard Group cut its Masimo stake by 9.6% in Q4, selling 461,225 shares and now owns 4,348,786 shares (about 8.10% of the company) valued at roughly $565.6 million.
• Masimo has a market capitalization of $9.57 billion, a negative trailing P/E of -16.91, and a 52-week range of $125.94 to $179.00, with the stock trading near its recent highs.
• Analysts are cautious: the consensus rating is "Reduce" with an average target price of $181.17, and multiple firms have downgraded the stock to Hold/Market Perform.

Vanguard Group Inc. cut its holdings in Masimo Corporation (NASDAQ:MASI - Free Report) by 9.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,348,786 shares of the medical equipment provider's stock after selling 461,225 shares during the period. Vanguard Group Inc. owned 8.10% of Masimo worth $565,603,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Masimo by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider's stock valued at $1,894,000 after purchasing an additional 66 shares during the period. Clearstead Advisors LLC boosted its holdings in Masimo by 18.4% in the 3rd quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider's stock valued at $69,000 after purchasing an additional 73 shares during the period. Assetmark Inc. lifted its holdings in shares of Masimo by 5.5% during the 4th quarter. Assetmark Inc. now owns 1,850 shares of the medical equipment provider's stock worth $241,000 after acquiring an additional 97 shares during the last quarter. Orion Porfolio Solutions LLC lifted its holdings in shares of Masimo by 2.2% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 4,871 shares of the medical equipment provider's stock worth $819,000 after acquiring an additional 104 shares during the last quarter. Finally, Smartleaf Asset Management LLC lifted its holdings in shares of Masimo by 80.0% during the 3rd quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider's stock worth $44,000 after acquiring an additional 136 shares during the last quarter. 85.96% of the stock is owned by institutional investors.

Masimo Stock Performance

NASDAQ MASI opened at $178.21 on Tuesday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.47 and a current ratio of 2.49. The company has a market capitalization of $9.57 billion, a P/E ratio of -16.91, a P/E/G ratio of 1.81 and a beta of 1.13. The company has a fifty day moving average of $177.21 and a 200-day moving average of $153.98. Masimo Corporation has a 52-week low of $125.94 and a 52-week high of $179.00.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. Stifel Nicolaus set a $180.00 price objective on shares of Masimo in a report on Tuesday, February 17th. Raymond James Financial downgraded shares of Masimo from an "outperform" rating to a "market perform" rating in a report on Friday, March 27th. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Masimo in a report on Thursday, January 22nd. Wells Fargo & Company raised shares of Masimo to a "hold" rating in a report on Wednesday, March 18th. Finally, Piper Sandler downgraded shares of Masimo from an "overweight" rating to a "hold" rating and set a $180.00 price objective for the company. in a report on Tuesday, February 17th. Eight investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Masimo currently has a consensus rating of "Reduce" and an average target price of $181.17.

Masimo Company Profile

Masimo NASDAQ: MASI is a global medical technology company specializing in noninvasive monitoring solutions. The company's flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo's portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.